Last reviewed · How we verify

Pregnancy with abortive outcome — Treatment Landscape & Competitive Intelligence

Pregnancy with abortive outcome (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Pregnancy with abortive outcome, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Mifeprex MIFEPRISTONE Corcept Therap Progestin Antagonist [EPC] Glucocorticoid receptor 2000-01-01
Oxytocin 5 Usp Units In Dextrose 5% OXYTOCIN Fresenius Kabi Adrenocorticotropic Hormone [EPC] Oxytocin receptor 1980-01-01
Hemabate CARBOPROST Pfizer Prostaglandin Analog Prostaglandin F2-alpha receptor 1979-01-01
Prepidil DINOPROSTONE Pfizer Prostaglandin Analog [EPC] Prostaglandin E2 receptor EP4 subtype 1977-01-01
Enzaprost DINOPROST Pfizer dinoprost Prostaglandin F2-alpha receptor 1976-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. Pfizer · 3 drugs in Pregnancy with abortive outcome
  2. Corcept Therap · 1 drug in Pregnancy with abortive outcome
  3. Fresenius Kabi · 1 drug in Pregnancy with abortive outcome

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Pregnancy with abortive outcome:

Cite this brief

Drug Landscape (2026). Pregnancy with abortive outcome — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/pregnancy-with-abortive-outcome. Accessed 2026-06-10.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing